Compare Illumina, Inc. (ILMN) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs United States Oil ETF — how do they compare? Illumina, Inc. trades at $264.95 (market cap $39.95B), while United States Oil ETF trades at $146.78 (market cap $1.90B). The key difference: Illumina, Inc. is far larger — about 21× United States Oil ETF's market cap, and United States Oil ETF is more actively traded (5,932,922 versus 3,169,503). Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and United States Oil ETF for 21 Days on average.
| ILMN | USO | |
|---|---|---|
Market Cap | $39.95B | $1.90B |
Volume | 3,169,503 | 5,932,922 |
Sector | Health | — |
52-Week High | $293.69 | $161.86 |
52-Week Low | $91.00 | $66.17 |
Typical Hold Time | 83 Days | 21 Days |
Enterprise Value | $41.31B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $267.76, down 2.11% on the day but remains near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and a significant return to profitability in 2025 highlight fundamental improvement. Positive sentiment is fueled by S&P 500 inclusion and analyst upgrades, though high valuation ratios present a risk.
The outlook is cautiously optimistic, driven by sequencing growth and AI initiatives, but investors face risks from elevated valuations, competitive pressures, and potential margin volatility. The consensus price target of $241 suggests near-term downside from current levels despite a majority of analysts maintaining a Buy rating.
USO trades at $143.91, down 0.7% amid mixed oil market signals. Technical indicators show neutral sentiment with bearish moving averages, while support levels cluster around $140-142. Recent news highlights Middle East tensions and OPEC+ production decisions creating supply uncertainty. The stock faces headwinds from coordinated G-7 reserve releases but benefits from geopolitical risk premiums.
Outlook remains balanced with technical support providing downside protection while geopolitical risks and supply dynamics drive volatility. Investment opportunity exists for traders capitalizing on oil price swings, though fundamental data limitations require careful risk management given the commodity-sensitive nature of this energy-focused security.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
